Ensysce Biosciences Inc (ENSC) — Cash Flow Quality Index

Latest as of September 2024: -1.54x

Ensysce Biosciences Inc (ENSC) has a Cash Flow Quality Index of -1.54x as of September 2024. Operating cash flow of $-1.02 Million is below net income of $661.77K, suggesting accrual-heavy earnings not yet converted to cash. Explore ENSC operating cash flow to assess how effectively this company generates cash.

Cash Flow Quality Index

-1.54x
Operating CF / Net Income

Operating Cash Flow

$-1.02 Million
USD

Net Income

$661.77K
USD

Data as of

Sep 2024
Most recent filing

Ensysce Biosciences Inc Cash Flow Quality Index (2019–2019)

Historical Cash Flow Quality Index for Ensysce Biosciences Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Ensysce Biosciences Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Ensysce Biosciences Inc (2019–2019)

Year-by-year earnings quality comparison for Ensysce Biosciences Inc. For live market cap and the full company financial profile, see Ensysce Biosciences Inc (ENSC) market capitalisation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2019 30.04x $10.99 Million $365.95K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.